IDEAYA Biosciences Announces IND Clearance for Werner Helicase Development Candidate IDE275 GSK959 for a Phase 1 Study in MSI High Solid Tumors
Monday, October 28, 2024 1 min read
Key Takeaway: IDEAYA Biosciences Announces IND Clearance for Werner Helicase Development Candidate IDE275 GSK959 for a Phase 1 Study in MSI High Solid Tumors
Full Press Release Details
IDEAYA Biosciences Announces IND Clearance for Werner Helicase Development Candidate IDE275 GSK959 for a Phase 1 Study in MSI High Solid Tumors.